Lenvatinib and Pembrolizumab Simultaneous Combination Study

Clinical trial NCT03609359 · COMPLETED

Trial details

NCT number: NCT03609359
Sponsor: National Cancer Center Hospital East
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer

Start date: 2018-10-03
Primary completion: 2021-04-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.